|
US8715940B2
(en)
*
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
|
PL205955B1
(pl)
*
|
2000-04-28 |
2010-06-30 |
St Jude Childrens Res Hospital |
Układ oparty na minimalnej liczbie plazmidów do wytwarzania infekcyjnych wirusów RNA o ujemnej nici, komórka gospodarza zawierająca taki układ, sposób wytwarzania wiriona wirusa RNA o ujemnej nici, sposób wytwarzania atenuowanego wirusa RNA o ujemnej nici, sposób wytwarzania zakaźnego wirusa o ujemnej nici do stosowania w szczepionkach i zastosowanie układu opartego na minimalnej liczbie plazmidów
|
|
EP1499348B1
(en)
|
2002-04-26 |
2014-10-01 |
MedImmune, LLC |
Method for producing infectious influenza b virus in cell culture
|
|
US7465456B2
(en)
*
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
DK1375670T3
(da)
*
|
2002-06-20 |
2013-09-23 |
Pasteur Institut |
Rekombinante mæslingevira, der udtrykker epitoper af RNA-viras antigener, samt anvendelse af de rekombinante vira til fremstilling af vaccinesammensætninger
|
|
EP2110382A1
(en)
*
|
2002-06-20 |
2009-10-21 |
Institut Pasteur |
Infectious cDNA of an improved vaccine strain of measles virus, use for immunogenic compositions
|
|
DE10248301A1
(de)
*
|
2002-10-16 |
2004-04-29 |
Philipps-Universität Marburg |
Herstellung eines Lebend-Impfstoffes gegen Influenza-Viren
|
|
US20060110406A1
(en)
*
|
2003-02-25 |
2006-05-25 |
Medimmune Vaccines, Inc. |
Refrigerator-temperature stable influenza vaccine compositions
|
|
US7262045B2
(en)
|
2003-02-25 |
2007-08-28 |
Medimmune Vaccines, Inc. |
Methods of producing influenza vaccine compositions
|
|
CA2432738A1
(en)
|
2003-02-26 |
2004-08-26 |
Philippe Despres |
New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
|
|
WO2005028658A2
(en)
*
|
2003-05-28 |
2005-03-31 |
Wisconsin Alumni Research Foundation |
Recombinant influenza vectors with a polii promoter and ribozymes
|
|
EA012965B1
(ru)
*
|
2003-05-28 |
2010-02-26 |
Висконсин Эламни Рисёч Фаундэйшн |
Композиция для получения реассортантного рекомбинантного вируса гриппа, способ получения указанного вируса и реассортантный рекомбинантный вирус гриппа
|
|
WO2005018539A2
(en)
*
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
US7037707B2
(en)
*
|
2003-09-04 |
2006-05-02 |
St. Jude Children's Research Hospital |
Method for generating influenza viruses and vaccines
|
|
AU2004308328B2
(en)
*
|
2003-12-23 |
2009-06-04 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
DE202005022108U1
(de)
|
2004-03-09 |
2013-11-12 |
Novartis Vaccines And Diagnostics, Inc. |
Influenza-Virus-Impfstoffe
|
|
DE102004013335A1
(de)
*
|
2004-03-17 |
2005-10-13 |
TransMIT Gesellschaft für Technologietransfer mbH |
Impfstoff gegen Influenza basierend auf Geflügelpestviren
|
|
ES2647491T3
(es)
*
|
2004-05-21 |
2017-12-21 |
Novartis Vaccines And Diagnostics, Inc. |
Vectores del alfavirus para las vacunas del virus de la gripe
|
|
HUE025727T2
(en)
|
2004-05-24 |
2016-04-28 |
Medimmune Llc |
Multi-plasmid system for producing influenza virus
|
|
EP2902484A1
(en)
|
2004-05-25 |
2015-08-05 |
MedImmune, LLC |
Influenza hemagglutinin and neuraminidase variants
|
|
ES2633471T3
(es)
|
2004-10-06 |
2017-09-21 |
Medimmune, Llc |
Composiciones de vacuna contra la gripe estables a temperatura de refrigerador
|
|
EP1814990A2
(en)
|
2004-11-19 |
2007-08-08 |
Wisconsin Alumni Research Foundation |
Recombinant influenza vectors with tandem transcription units
|
|
EP1824990B1
(en)
*
|
2004-12-08 |
2015-02-18 |
MedImmune, LLC |
Methods of producing influenza vaccine compositions
|
|
DK2368975T3
(en)
|
2004-12-23 |
2015-01-05 |
Medimmune Llc |
Non-tumorigenic MDCK cell line for the propagation of viruses
|
|
EP2295542B1
(en)
*
|
2004-12-24 |
2013-01-30 |
Abbott Biologicals B.V. |
Rescue of influenza virus
|
|
ES2527503T3
(es)
|
2005-03-08 |
2015-01-26 |
Medimmune, Llc |
Virus influenza reordenantes
|
|
EP2489739B1
(en)
*
|
2005-04-21 |
2019-11-20 |
University of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
|
US7790434B2
(en)
*
|
2005-06-21 |
2010-09-07 |
Medimmune, Llc |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
|
US20060286591A1
(en)
|
2005-06-21 |
2006-12-21 |
Medimmune Vaccines, Inc. |
Methods and compositions for expressing negative-sense viral RNA in canine cells
|
|
AU2006304898B2
(en)
|
2005-10-17 |
2011-11-10 |
Medimmune, Llc |
Multi-plasmid system for the production of influenza virus
|
|
US11707520B2
(en)
|
2005-11-03 |
2023-07-25 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
US20090220541A1
(en)
|
2005-11-04 |
2009-09-03 |
Novartis Vaccines And Diagnostics Srl |
Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccines
|
|
WO2007052155A2
(en)
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics Srl |
Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
|
|
WO2007052059A2
(en)
*
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics Srl |
Changing th1/th2 balance in split influenza vaccines with adjuvants
|
|
ES2377884T3
(es)
|
2005-11-04 |
2012-04-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
|
|
PL2368572T3
(pl)
|
2005-11-04 |
2020-11-16 |
Seqirus UK Limited |
Szczepionki z adjuwantem z niewirionowymi antygenami otrzymane z wirusów grypy hodowanych w hodowli komórkowej
|
|
NZ567979A
(en)
|
2005-11-04 |
2012-02-24 |
Novartis Vaccines & Diagnostic |
Adjuvanted influenza vaccines including a cytokine-inducing agents which is an agonist of Toll-Like Receptor 7
|
|
BR122019013216B8
(pt)
|
2006-01-27 |
2021-07-27 |
Seqirus Uk Ltd |
ensaio imunológico para análise de uma vacina contra influenza
|
|
JP2009534303A
(ja)
|
2006-03-24 |
2009-09-24 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
冷蔵しないインフルエンザワクチンの保存
|
|
CN101472941B
(zh)
|
2006-03-31 |
2017-08-08 |
沃弗-威斯康星校友研究基金会 |
用于疫苗的高滴度重组流感病毒
|
|
AU2014202470B2
(en)
*
|
2006-03-31 |
2016-08-04 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
AU2012204138B2
(en)
*
|
2006-03-31 |
2014-02-06 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
JP5491173B2
(ja)
|
2006-04-19 |
2014-05-14 |
メディミューン，エルエルシー |
イヌ細胞中でマイナス鎖ウイルスｒｎａを発現させるための方法および組成物
|
|
US9072701B2
(en)
|
2006-04-21 |
2015-07-07 |
St. Jude Children's Research Hospital |
Avian influenza viruses, vaccines, compositions, formulations, and methods
|
|
US7507411B2
(en)
*
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
|
EP2049662A4
(en)
*
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
|
|
JP2010500034A
(ja)
*
|
2006-08-09 |
2010-01-07 |
メッドイミューン バクシーンズ，インコーポレイティド |
インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体
|
|
EP3456348B1
(en)
|
2006-09-11 |
2025-03-26 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
|
KR101464783B1
(ko)
|
2006-09-15 |
2014-11-26 |
메디뮨 엘엘씨 |
높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
|
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
|
PL2121011T3
(pl)
|
2006-12-06 |
2014-10-31 |
Novartis Ag |
Szczepionki zawierające antygeny czterech szczepów wirusa grypy
|
|
WO2008080091A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Vical Incorporated |
Activation of rig-i pathway
|
|
WO2008153236A1
(en)
*
|
2007-06-15 |
2008-12-18 |
Protheon Co., Ltd |
An attenuated influenza virus and a live vaccine comprising the same
|
|
EP2674486A1
(en)
|
2007-06-18 |
2013-12-18 |
MedImmune, LLC |
Influenza B viruses having alterations in the hemaglutinin polypeptide
|
|
WO2008156778A2
(en)
|
2007-06-18 |
2008-12-24 |
Tokiko Watanabe |
Influenza m2 protein mutant viruses as live influenza attenuated vaccines
|
|
CN101784283A
(zh)
|
2007-06-27 |
2010-07-21 |
诺华有限公司 |
低添加流感疫苗
|
|
EP2045323A1
(en)
*
|
2007-10-05 |
2009-04-08 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Linear expression constructs for production of influenza virus particles
|
|
US8088593B2
(en)
|
2007-10-02 |
2012-01-03 |
Theranos, Inc. |
Modular point-of-care devices, systems, and uses thereof
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
WO2009068870A1
(en)
*
|
2007-11-26 |
2009-06-04 |
London School Of Hygiene & Tropical Medicine |
Method for producing vaccinal viral strain of a virus of the reoviridae family
|
|
EP2268309B1
(en)
|
2008-03-18 |
2015-01-21 |
Novartis AG |
Improvements in preparation of influenza virus vaccine antigens
|
|
RU2523587C2
(ru)
|
2008-07-11 |
2014-07-20 |
МЕДИММЬЮН, ЭлЭлСи |
Варианты гемагглютинина и нейрамидазы вируса гриппа
|
|
KR20110074563A
(ko)
|
2008-09-24 |
2011-06-30 |
메디뮨 엘엘씨 |
바이러스의 정제 방법
|
|
EP2233568A1
(en)
*
|
2009-03-19 |
2010-09-29 |
Avir Green Hills Biotechnology Research Development Trade AG |
Novel method for generation of RNA virus
|
|
ES2552383T3
(es)
|
2009-02-10 |
2015-11-27 |
Novartis Ag |
Regímenes de vacuna de la gripe para cepas asociadas a pandemias
|
|
AU2010212550B2
(en)
|
2009-02-10 |
2016-03-10 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
AU2010212548A1
(en)
|
2009-02-10 |
2011-09-15 |
Novartis Ag |
Influenza vaccines with increased amounts of H3 antigen
|
|
EP2396033B1
(en)
|
2009-02-12 |
2016-09-28 |
MedImmune, LLC |
Influenza hemagglutinin and neuraminidase variants
|
|
JP2012521786A
(ja)
|
2009-03-30 |
2012-09-20 |
モウント シナイ スクール オフ メディシネ |
インフルエンザウイルスワクチン及びその使用
|
|
FR2949344A1
(fr)
|
2009-04-27 |
2011-03-04 |
Novartis Ag |
Vaccins de protection contre la grippe
|
|
WO2010144797A2
(en)
|
2009-06-12 |
2010-12-16 |
Vaccine Technologies, Incorporated |
Influenza vaccines with enhanced immunogenicity and uses thereof
|
|
WO2011014504A1
(en)
|
2009-07-27 |
2011-02-03 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza virus vectors and uses thereof
|
|
CA2805505C
(en)
|
2009-07-30 |
2021-08-03 |
Mount Sinai School Of Medecine |
Chimeric influenza viruses having reduced ability to reassort with other influenza viruses and uses thereof
|
|
EP2459722B1
(en)
|
2009-07-31 |
2017-09-06 |
Seqirus UK Limited |
Reverse genetics systems
|
|
WO2011030218A1
(en)
|
2009-09-10 |
2011-03-17 |
Novartis Ag |
Combination vaccines against respiratory tract diseases
|
|
WO2011048560A1
(en)
*
|
2009-10-20 |
2011-04-28 |
Novartis Ag |
Improved reverse genetics methods for virus rescue
|
|
JP2013507990A
(ja)
|
2009-10-26 |
2013-03-07 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
|
|
CN102051345B
(zh)
*
|
2009-11-09 |
2013-04-17 |
中国医学科学院医药生物技术研究所 |
一种抗流行性感冒病毒药物的筛选方法
|
|
US9701723B2
(en)
*
|
2010-02-18 |
2017-07-11 |
Icahn School Of Medicine At Mount Sinai |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
MX2012011300A
(es)
|
2010-03-30 |
2012-11-29 |
Sinai School Medicine |
Vacunas del virus de influenza y usos de las mismas.
|
|
WO2011151470A2
(en)
|
2010-06-02 |
2011-12-08 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Novel method for generation of rna virus
|
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
|
CN106323875B
(zh)
|
2011-01-21 |
2019-07-09 |
西拉诺斯知识产权有限责任公司 |
样品使用最大化的系统和方法
|
|
WO2012108195A1
(ja)
*
|
2011-02-08 |
2012-08-16 |
国立大学法人三重大学 |
遺伝子導入用ウイルスベクターの製造方法
|
|
US20130189303A1
(en)
|
2011-08-02 |
2013-07-25 |
Yan Zhou |
Recombinant swine influenza virus and uses thereof
|
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
|
ES2655051T3
(es)
|
2011-08-26 |
2018-02-16 |
Wisconsin Alumni Research Foundation |
Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
|
|
US8475739B2
(en)
|
2011-09-25 |
2013-07-02 |
Theranos, Inc. |
Systems and methods for fluid handling
|
|
US9664702B2
(en)
|
2011-09-25 |
2017-05-30 |
Theranos, Inc. |
Fluid handling apparatus and configurations
|
|
US20140170735A1
(en)
|
2011-09-25 |
2014-06-19 |
Elizabeth A. Holmes |
Systems and methods for multi-analysis
|
|
US9632102B2
(en)
|
2011-09-25 |
2017-04-25 |
Theranos, Inc. |
Systems and methods for multi-purpose analysis
|
|
HK1200102A1
(en)
|
2011-09-20 |
2015-07-31 |
西奈山医学院 |
Influenza virus vaccines and uses thereof
|
|
US10012664B2
(en)
|
2011-09-25 |
2018-07-03 |
Theranos Ip Company, Llc |
Systems and methods for fluid and component handling
|
|
US9810704B2
(en)
|
2013-02-18 |
2017-11-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
|
EP2764015A1
(en)
|
2011-10-07 |
2014-08-13 |
Medlmmune, LLC |
Influenza hemagglutinin variants
|
|
US20140248320A1
(en)
|
2011-10-20 |
2014-09-04 |
Novartis Ag |
Adjuvanted influenza b virus vaccines for pediatric priming
|
|
CN104704112A
(zh)
|
2012-08-03 |
2015-06-10 |
赛诺菲巴斯德 |
传染性流感病毒的生产
|
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
|
NZ627796A
(en)
|
2012-12-18 |
2017-07-28 |
Icahn School Med Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
US10401373B1
(en)
|
2013-02-18 |
2019-09-03 |
Theranos Ip Company, Llc |
Systems and methods for analyte testing and laboratory oversight
|
|
US11008628B1
(en)
|
2013-02-18 |
2021-05-18 |
Labrador Diagnostics Llc |
Systems and methods for analyte testing and laboratory oversight
|
|
WO2014127825A1
(en)
|
2013-02-21 |
2014-08-28 |
Boehringer Ingelheim Vetmedica Gmbh |
H5 proteins of h5n1 influenza virus for use as a medicament
|
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
WO2015009743A1
(en)
|
2013-07-15 |
2015-01-22 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
|
|
US10422806B1
(en)
|
2013-07-25 |
2019-09-24 |
Theranos Ip Company, Llc |
Methods for improving assays of biological samples
|
|
ES2813367T3
(es)
|
2013-12-09 |
2021-03-23 |
Sangamo Therapeutics Inc |
Métodos y composiciones para ingeniería genómica
|
|
CN103757032B
(zh)
*
|
2014-01-28 |
2017-06-06 |
中国人民解放军第三0二医院 |
一种以流感病毒为载体的hcv嵌合疫苗及其制备方法
|
|
AU2015218576B2
(en)
|
2014-02-24 |
2020-02-27 |
Sangamo Therapeutics, Inc. |
Methods and compositions for nuclease-mediated targeted integration
|
|
US11360107B1
(en)
|
2014-02-25 |
2022-06-14 |
Labrador Diagnostics Llc |
Systems and methods for sample handling
|
|
JP6594891B2
(ja)
|
2014-03-18 |
2019-10-23 |
サンガモ セラピューティクス， インコーポレイテッド |
ジンクフィンガータンパク質発現を調節するための方法および組成物
|
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
MA40772A
(fr)
*
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
|
MA40773A
(fr)
*
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
|
CN104450695B
(zh)
*
|
2014-11-26 |
2017-08-25 |
扬州大学 |
A型流感病毒基因pcr扩增引物及其快速克隆方法
|
|
US10889834B2
(en)
|
2014-12-15 |
2021-01-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing targeted transgene integration
|
|
EP3247389A4
(en)
|
2015-01-23 |
2019-10-30 |
Icahn School of Medicine at Mount Sinai |
INFLUENZAVIRUSSCHUTZIMPFPLÄNE
|
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
|
US10927151B2
(en)
|
2015-06-09 |
2021-02-23 |
Sanofi Pasteur Inc. |
Methods of optimizing nucleotide sequences encoding engineered influenza proteins
|
|
KR20180035807A
(ko)
|
2015-06-26 |
2018-04-06 |
세퀴러스 유케이 리미티드 |
항원적으로 매치된 인플루엔자 백신
|
|
WO2017007839A1
(en)
|
2015-07-06 |
2017-01-12 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
|
WO2017005880A1
(en)
|
2015-07-07 |
2017-01-12 |
Seqirus UK Limited |
Influenza potency assays
|
|
JP6624736B2
(ja)
*
|
2015-11-18 |
2019-12-25 |
国立研究開発法人農業・食品産業技術総合研究機構 |
インフルエンザウイルス解析装置、インフルエンザウイルス解析方法及びインフルエンザウイルス解析プログラム
|
|
CN109477074B
(zh)
|
2016-02-19 |
2023-01-24 |
威斯康星旧生研究基金会 |
用于疫苗开发的改进的乙型流感病毒复制
|
|
EP3464328A1
(en)
|
2016-06-02 |
2019-04-10 |
Sanofi Pasteur Inc. |
Engineered influenza antigenic polypeptides and immunogenic compositions thereof
|
|
MX2018015755A
(es)
|
2016-06-15 |
2019-08-29 |
Icahn School Med Mount Sinai |
Proteinas de hemaglutinina de virus de influenza y usos de las mismas.
|
|
BR112019010830A2
(pt)
|
2016-11-30 |
2019-10-01 |
Boehringer Ingelheim Animal Health Usa Inc |
vacinas atenuadas de influenza suína e métodos de produção e uso das mesmas
|
|
CA3058652A1
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
|
WO2019084310A1
(en)
|
2017-10-25 |
2019-05-02 |
Yoshihiro Kawaoka |
HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
|
|
JP7432506B2
(ja)
|
2017-10-30 |
2024-02-16 |
武田薬品工業株式会社 |
脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
|
|
US12364746B2
(en)
|
2018-06-21 |
2025-07-22 |
Icahn School Of Medicine At Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
JP7783047B2
(ja)
|
2018-08-07 |
2025-12-09 |
ウィスコンシン アルムニ リサーチ ファンデイション |
組換えの生物学的に封じ込められたフィロウイルスワクチン
|
|
EP3840780A1
(en)
|
2018-08-20 |
2021-06-30 |
Wisconsin Alumni Research Foundation |
Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein
|
|
WO2020167432A2
(en)
|
2019-01-23 |
2020-08-20 |
Yoshihiro Kawaoka |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
|
CA3137160A1
(en)
|
2019-04-24 |
2020-10-29 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
|
US12616745B2
(en)
|
2019-06-07 |
2026-05-05 |
Flugen, Inc. |
Influenza virus backbone
|
|
JP7627911B2
(ja)
|
2019-08-27 |
2025-02-07 |
ウィスコンシン アルムニ リサーチ ファンデイション |
卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
|
|
EP4093415A1
(en)
|
2020-01-24 |
2022-11-30 |
Wisconsin Alumni Research Foundation (WARF) |
Recombinant influenza viruses with stabilized na
|
|
US12290562B2
(en)
|
2020-03-25 |
2025-05-06 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
MX2023000881A
(es)
|
2020-07-21 |
2023-02-22 |
Flugen Inc |
Estructura genomica del virus de la influenza.
|
|
US12569550B2
(en)
*
|
2020-09-02 |
2026-03-10 |
St. Jude Children's Research Hospital, Inc. |
Hemagglutinin modifications for improved influenza vaccine production
|
|
BR112023004433A2
(pt)
*
|
2020-09-11 |
2023-04-11 |
Univ Georgia |
Ácido nucleico, vetor, segmento genômico viral, vírus, composição farmacêutica, método para induzir ou aumentar uma resposta imune contra o vírus influenza, vírus recombinante, método para induzir uma resposta imune em um sujeito em necessidade e polipeptídeo
|
|
KR102614346B1
(ko)
|
2020-12-14 |
2023-12-14 |
서울대학교산학협력단 |
Ｈ5ｎ6 재조합 인플루엔자 바이러스, 이의 제조용 조성물, 및 이를 포함하는 백신 조성물
|
|
CN113846100B
(zh)
*
|
2021-09-24 |
2026-05-08 |
江苏省农业科学院 |
利用基因编辑技术提高水稻植株对水稻黑条矮缩病毒抗性
|
|
JP2026511127A
(ja)
|
2023-03-22 |
2026-04-10 |
レンティテック リミテッド |
発現コンストラクト
|
|
WO2025019631A1
(en)
|
2023-07-19 |
2025-01-23 |
Icahn School Of Medicine At Mount Sinai |
Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof
|
|
WO2025072889A1
(en)
*
|
2023-09-28 |
2025-04-03 |
E & E Bioclub Llc |
Helper-free rescue system for negative-strand rna viruses
|
|
WO2025075855A1
(en)
*
|
2023-10-03 |
2025-04-10 |
St. Jude Children's Research Hospital, Inc. |
Reverse genetics vector and associated method of use
|